TY - THES A1 - Pilgrim, Sabine T1 - Entwicklung eines "DNA-Delivery"-Systems auf der Basis von Virulenz-attenuierten Listerien T1 - Development of a DNA delivery system using virulence-attenuated Listeria strains N2 - Virulenz-attenuierte Bakterien sind geeignete Vektoren für den Transport von Vakzine-DNA in das Zytosol von Antigen-präsentierenden Zellen ("DNA delivery"). In dieser Arbeit wurde dazu das intrazelluläre Bakterium Listeria monocytogenes verwendet, welches sich im Zytosol von Zellen vermehrt und fortbewegt. Ausgestattet mit einer intrazellulären Lysis-Kassette kann Listeria in vitro effektiv Plasmid-DNA in das Zytosol verschiedener Zelltypen freisetzen. Zur Virulenz-Attenuierung wurde das Gen iap im Chromosom des Bakteriums deletiert. Der daraus resultierte Stamm, in Folgenden als iap bezeichnet, erwies sich als hoch attenuiert im Modell der murinen Listeriose. Diese Attenuation konnte auf einen Defekt in der Beweglichkeit der Bakterien innerhalb von Wirtszellen zurückgeführt werden, da sich bei diesem Stamm das Protein ActA, das essentiell für die Aktin-basierte Motilität von L. monocytogenes ist, fehlerhaft auf der Oberfläche der Bakterien anordnet. Zusätzlich konnte demonstriert werden, dass iap in der Zellteilung beeinträchtigt ist und deshalb eine veränderte Morphologie aufweist. Im Rahmen dieser Arbeit wurde ein so genanntes "Balanced-lethal" System etabliert. Dazu wurde das essentielle Gens trpS im Chromosom deletiert, während gleichzeitig eine trpS-Expressions-Kassette auf einem Vakzine-Plasmid inseriert wurde. Dieses System gewährleistet, dass das Trägerbakterium dieses Plasmid weder in vitro noch in vivo verliert. Dies ist besonders wichtig im Hinblick auf eine bakteriolytische Lysis-Kassette, welche ebenfalls auf diesem Plasmid kodiert ist. Es wurden verschiedene Lysis-Kassetten, die alle aus einem Listeria-spezifischen Phagenlysin und einem vorangestellten zytosolischen listeriellen Promotor zusammengesetzt waren, miteinander verglichen. Dabei wurde beobachtet, dass die für die Übertragung von Plasmid-DNA in das Zytosol von Wirtszellen wirksamste Phagenlysin-Kassette (PactA-ply118) die Bakterien in vitro nur partial abtötet, während sie in vivo zu einer besonders hohen Attenuation der Bakterien führt. Unter Verwendung dieses "DNA delivery" Systems wurden Mäuse oral mit Listerien infiziert, die ein DNA-Vakzine-Plasmid zur Expression des Leishmania Antigens KMP-11 trugen. Dabei konnte bei 27 % aller Tiere, die zweimal mit diesen Listerien infiziert worden sind, eine KMP-11 spezifische, proliferative Immunantwort gemessen werden. Listerien, die einen Defekt in ihrer Motilität besitzen (delta-iap, delta-actA), erwiesen sich darin beeinträchtigt, Plasmid-DNA im Zytosol von Zellen freizusetzen. Anhand dieser Stämme konnte gezeigt werden, dass die Fähigkeit von L. monocytogenes, sich innerhalb von Zellen zu bewegen und in benachbarte Zellen einzudringen eine wichtige Voraussetzung für einen effizienten Transfer von Plasmid-DNA in vitro darstellt. N2 - Virulence-attenuated bacteria are useful carriers to introduce a DNA vaccine into antigen presenting cells (DNA delivery). To this end, the intracellular bacterium Listeria monocytogenes was used in this work, which is able to replicate and spread inside host cells. Hence Listeriae are able to efficiently release plasmid DNA within the cytosol in vitro when they are provided with a cytosolic lysis cassette. The expression of the antigen by the cell leads to the presentation of antigenic epitopes on the cell's major histocompatibilty complex (MHC) class I molecules, due to the antigen being endogenous. This stimulates the activation of CD8+ T cells which are important for clearance of tumours, parasites and virus infected cells. In order to create a virulence-attenuated carrier strain the gene iap was deleted in the chromosome of the bacterium. The resulting strain, designated as iap, was shown to be highly attenuated in mice. This was due to a defect of the intracellular motility since ActA, a protein which is necessary for actin-based motility of Listeria, was localised incorrectly at the bacterial surface. Additionally, it was demonstrated that iap is impaired in cell division which leads to an altered cell morphology. In this work a so-called balanced-lethal plasmid system was established. The essential gene trpS was deleted from the chromosome of L. monocytogenes and a trpS transcription unit was inserted in a vaccine DNA plasmid thus ensuring that no plasmid loss happens in vitro and also within the host organism. This is in particular important in terms of a bacteriolytic lysis cassette which is also encoded by the plasmid. Different lysis cassettes were tested consisting of a Listeria-specific phage lysin and an intracellular promoter of Listeria. The cassette PactA-ply118 was found the be most effective due to its DNA delivery capacity but it mediates only a partial lysis of the intracellular bacteria. However, this cassette leads to a high attenuation of Listeria in mice. Using this DNA delivery system mice were orally infected with Listeria harbouring a KMP-11 expression plasmid. 27 % of animals infected twice exhibited a specific proliferative response to the leismanial antigen KMP-11. Listeriae with a defect in their spreading capacity (delta-iap, delta-actA) were impaired in the cytosolic release of plasmid DNA. With these strains it was demonstrated, that spreading is an important prerequisite for L. monocytogenes to be an efficient DNA delivery carrier in vitro. KW - Listeria monocytogenes KW - Gentransfer KW - Listeria KW - Gentransfer KW - Vakzinierung KW - p60 KW - "Balanced-lethal" Plasmid-System KW - Listeria KW - DNA delivery KW - vaccine KW - p60 KW - balanced-lethal plasmid system Y1 - 2002 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-4754 ER - TY - JOUR A1 - Roier, Sandro A1 - Leitner, Deborah R. A1 - Iwashkiw, Jeremy A1 - Schild-Prüfert, Kristina A1 - Feldman, Mario F. A1 - Krohne, Georg A1 - Reidl, Joachim A1 - Schild, Stefan T1 - Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice JF - PLoS One N2 - Haemophilus influenzae is a Gram-negative human-restricted bacterium that can act as a commensal and a pathogen of the respiratory tract. Especially nontypeable H. influenzae (NTHi) is a major threat to public health and is responsible for several infectious diseases in humans, such as pneumonia, sinusitis, and otitis media. Additionally, NTHi strains are highly associated with exacerbations in patients suffering from chronic obstructive pulmonary disease. Currently, there is no licensed vaccine against NTHi commercially available. Thus, this study investigated the utilization of outer membrane vesicles (OMVs) as a potential vaccine candidate against NTHi infections. We analyzed the immunogenic and protective properties of OMVs derived from various NTHi strains by means of nasopharyngeal immunization and colonization studies with BALB/c mice. The results presented herein demonstrate that an intranasal immunization with NTHi OMVs results in a robust and complex humoral and mucosal immune response. Immunoprecipitation revealed the most important immunogenic proteins, such as the heme utilization protein, protective surface antigen D15, heme binding protein A, and the outer membrane proteins P1, P2, P5 and P6. The induced immune response conferred not only protection against colonization with a homologous NTHi strain, which served as an OMV donor for the immunization mixtures, but also against a heterologous NTHi strain, whose OMVs were not part of the immunization mixtures. These findings indicate that OMVs derived from NTHi strains have a high potential to act as a vaccine against NTHi infections. KW - conjugate KW - obstructive pulmonary disease KW - vaccine KW - vibrio cholerae KW - detoxified lipooligosaccharide KW - nasopharyngeal colonization KW - functional characterization KW - growing escherichia coli KW - DNA-binding vesicles KW - otitis media KW - hemophilus influenzae Y1 - 2012 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-135201 VL - 7 IS - 8 ER - TY - JOUR A1 - Singh, Amit K. A1 - Kingston, Joseph J. A1 - Gupta, Shishir K. A1 - Batra, Harsh V. T1 - Recombinant Bivalent Fusion Protein rVE Induces CD4+ and CD8+ T-Cell Mediated Memory Immune Response for Protection Against Yersinia enterocolitica Infection JF - Frontiers in Microbiology N2 - Studies investigating the correlates of immune protection against Yersinia infection have established that both humoral and cell mediated immune responses are required for the comprehensive protection. In our previous study, we established that the bivalent fusion protein (rVE) comprising immunologically active regions of Y pestis LcrV (100-270 aa) and YopE (50-213 aa) proteins conferred complete passive and active protection against lethal Y enterocolitica 8081 challenge. In the present study, cohort of BALB/c mice immunized with rVE or its component proteins rV, rE were assessed for cell mediated immune responses and memory immune protection against Y enterocolitica 8081 rVE immunization resulted in extensive proliferation of both CD4 and CD8 T cell subsets; significantly high antibody titer with balanced IgG1: IgG2a/IgG2b isotypes (1:1 ratio) and up regulation of both Th1 (INF-\(\alpha\), IFN-\(\gamma\), IL 2, and IL 12) and Th2 (IL 4) cytokines. On the other hand, rV immunization resulted in Th2 biased IgG response (11:1 ratio) and proliferation of CD4+ T-cell; rE group of mice exhibited considerably lower serum antibody titer with predominant Th1 response (1:3 ratio) and CD8+ T-cell proliferation. Comprehensive protection with superior survival (100%) was observed among rVE immunized mice when compared to the significantly lower survival rates among rE (37.5%) and rV (25%) groups when IP challenged with Y enterocolitica 8081 after 120 days of immunization. Findings in this and our earlier studies define the bivalent fusion protein rVE as a potent candidate vaccine molecule with the capability to concurrently stimulate humoral and cell mediated immune responses and a proof of concept for developing efficient subunit vaccines against Gram negative facultative intracellular bacterial pathogens. KW - I-tasser KW - Yersinia enterocolitica KW - memory immune responses KW - cytokine profiling KW - CD8+T cells KW - CD4+T cells KW - recombinant protein rVE KW - resistance KW - pneumonic plague KW - pestis infection KW - nonhuman-primates KW - III secretion KW - V-antigen KW - mice KW - vaccine Y1 - 2015 U6 - http://nbn-resolving.de/urn/resolver.pl?urn:nbn:de:bvb:20-opus-136114 VL - 6 IS - 1407 ER -